Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s Net Profit Dropped 95.4% in First Three Quarters of 2023

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (002932.SZ) reported a net profit of 182.7 million yuan in the first three quarters of 2023, down 95.4% year-on-year.

Meanwhile, the company posted 625.9 million yuan in revenue, down 91.6% year-on-year.

At the end of the reporting period, it had 7.7 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 17.1%.